For decades, the standard of care for obstructive sleep apnea (OSA) has been tethered to a rigid metric: the 90-day compliance window. Under current Medicare guidelines and many private insurance policies, patients must prove they are using their Continuous Positive Airway Pressure (CPAP) machines for at least four hours a night, for 70% of nights within a 30-day period during the first three months of treatment. Failure to hit these specific targets often results in the immediate cessation of insurance coverage, effectively forcing the patient to return their device.
However, a landmark study presented at the American Thoracic Society (ATS) 2026 International Conference suggests that this "all-or-nothing" approach may be fundamentally flawed. By analyzing the habits of over 132,000 patients, researchers have uncovered evidence that early struggles with CPAP devices are not a harbinger of long-term failure, but rather a normal part of the adaptation process that should not be used as a justification to revoke life-saving therapy.
The Foundation of the Current Policy
To understand the significance of this research, one must first understand the origins of the 90-day threshold. The policy was established on the assumption that early adherence is a reliable proxy for long-term commitment to therapy. For years, the medical community operated under the premise that if a patient could not acclimate to the mask, pressure, and lifestyle changes associated with CPAP within the first three months, they were unlikely to do so thereafter.
Consequently, insurance payers adopted these thresholds as a financial safeguard, ensuring that resources were only allocated to patients who demonstrated immediate and sustained compliance. This created a high-pressure environment for patients, many of whom suffer from chronic fatigue, cognitive impairment, and other comorbidities linked to OSA. The anxiety of meeting these metrics—often while still learning to navigate the physical discomfort of the device—can, ironically, hinder the very comfort and consistency the policy seeks to encourage.
Chronology: A Shift in Clinical Perspective
The movement to challenge these arbitrary thresholds has been building for years as clinicians observed a disconnect between patient outcomes and insurance mandates.
- Pre-2020s: Clinical practices were largely governed by the Medicare-defined 90-day adherence rule, with little formal investigation into whether early non-adherence predicted long-term abandonment.
- 2023–2025: Increasing anecdotal evidence from sleep clinics suggested that many "non-compliant" patients were actually using their machines for significant periods, though falling just short of the four-hour mark.
- May 2026 (ATS Conference): Researchers from Kaiser Permanente Southern California presented their comprehensive analysis, marking the first time such a large-scale dataset was used to systematically debunk the predictive power of the 90-day rule.
- Present Day: The medical community is now calling for a transition toward outcomes-based coverage, where clinical improvement—rather than hours on a clock—dictates the continuation of care.
Supporting Data: What the Kaiser Permanente Study Revealed
The study conducted at Kaiser Permanente Southern California is notable not just for its methodology, but for the sheer volume of patient data analyzed. By looking at 132,000 patients within a system that covers CPAP therapy regardless of early adherence, researchers were able to observe "natural" usage patterns that are usually masked by insurance-driven data collection.
The findings were striking:
- High Rates of Early Non-Adherence: A staggering 51% of the study population failed to meet the Medicare criteria for continued use within the first 90 days.
- Persistence Despite Penalties: More than one-third of the patients who initially missed the criteria were still using their CPAP devices one year later.
- The "Two-Hour Benefit" Threshold: Researchers noted that many patients who failed to meet the four-hour goal were still using their machines for at least two hours a night. Clinical literature has long suggested that even two hours of usage can significantly improve symptoms and reduce the physiological strain caused by OSA, yet these patients were being flagged as failures under the current system.
The study effectively proves that early non-adherence does not equate to treatment failure. Instead, it suggests that a significant cohort of patients requires a "longer runway" to reach full compliance.
Official Responses and Clinical Implications
The lead author of the study, Dr. Dennis Hwang, a sleep and pulmonary physician at Kaiser Permanente Southern California, has been vocal about the need for systemic change. "Our findings suggest clinicians and policymakers should not rely solely on Medicare-defined adherence, given its reliance on early CPAP use and an arbitrary four-hour threshold, when making long-term treatment decisions," Dr. Hwang stated in a press release.
Dr. Hwang’s perspective reflects a growing consensus among sleep specialists: the "arbitrary" nature of the four-hour requirement ignores the nuanced realities of chronic disease management. For a patient adjusting to the life-altering diagnosis of sleep apnea, the first 90 days are often a period of trial and error regarding mask fit, humidity settings, and psychological acceptance. By pulling the rug out from under these patients precisely when they are most vulnerable, the current policy may be causing more harm than good.
The implications for policymakers are clear:
- Revising Coverage: Insurance providers must move toward a more flexible model that supports the patient’s transition into therapy rather than penalizing their initial learning curve.
- Redefining Success: Success should be measured by patient-reported symptom relief and physiological improvements, such as reduced daytime sleepiness and improved blood pressure, rather than a binary "met/not met" adherence score.
- Extending Support: Dr. Hwang emphasized that "extending support and coverage beyond the first 90 days could help more patients achieve meaningful benefit."
The Future of OSA Management
As the medical community digests these findings, the path forward involves a shift toward personalized, evidence-based care. The researchers involved in the Kaiser Permanente study are already planning follow-up investigations designed to identify which patient profiles are most likely to become long-term users, even if they start slowly.
The goal is to create a tiered system of support. Patients who struggle in the first month could be flagged for additional coaching, mask-fitting consultations, or behavioral therapy, rather than being discarded from the insurance program. By providing this additional layer of support, health systems can ensure that the investment in CPAP equipment leads to genuine health improvements rather than wasted resources.
Conclusion: A Call for Policy Reform
The 90-day CPAP compliance policy was born from a desire for efficiency and cost-containment. However, as the research from the ATS 2026 conference demonstrates, this efficiency has come at the expense of patient access and long-term health outcomes. When 51% of patients are classified as "non-compliant" despite a significant portion of them finding benefit in the therapy, the policy is no longer serving its intended purpose.
It is time for regulatory bodies and private insurers to move away from rigid, arbitrary thresholds and embrace a more empathetic, clinically sound approach to sleep apnea treatment. Patients suffering from OSA deserve a system that recognizes that health is a journey, not a sprint—and that a slow start should never be the reason a patient is denied the ability to breathe easier at night.
